These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23279201)

  • 1. Unusual imaging findings in brain and spinal cord in two siblings with maple syrup urine disease.
    Bhat M; Prasad C; Bindu PS; Aziz Z; Christopher R; Saini J
    J Neuroimaging; 2013 Oct; 23(4):540-2. PubMed ID: 23279201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India.
    Bindu PS; Shehanaz KE; Christopher R; Pal PK; Ravishankar S
    J Child Neurol; 2007 Jul; 22(7):911-3. PubMed ID: 17715290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases.
    Cheng A; Han L; Feng Y; Li H; Yao R; Wang D; Jin B
    Diagn Interv Radiol; 2017; 23(5):398-402. PubMed ID: 28830848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease.
    Schönberger S; Schweiger B; Schwahn B; Schwarz M; Wendel U
    Mol Genet Metab; 2004 May; 82(1):69-75. PubMed ID: 15110325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal maple syrup urine disease case report and literature review.
    Liu Q; Li F; Zhou J; Liu X; Peng J; Gong L
    Medicine (Baltimore); 2022 Dec; 101(50):e32174. PubMed ID: 36550798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted MRI of maple syrup urine disease encephalopathy.
    Cavalleri F; Berardi A; Burlina AB; Ferrari F; Mavilla L
    Neuroradiology; 2002 Jun; 44(6):499-502. PubMed ID: 12070724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Water apparent diffusion coefficient and T2 changes in the acute stage of maple syrup urine disease: evidence of intramyelinic and vasogenic-interstitial edema.
    Righini A; Ramenghi LA; Parini R; Triulzi F; Mosca F
    J Neuroimaging; 2003 Apr; 13(2):162-5. PubMed ID: 12722501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is demyelination a feature of maple syrup urine disease?
    Müller K; Kahn T; Wendel U
    Pediatr Neurol; 1993; 9(5):375-82. PubMed ID: 8292212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic tools of early brain disturbances in an asymptomatic neonate with maple syrup urine disease.
    Terek D; Koroglu O; Yalaz M; Gokben S; Calli C; Coker M; Kultursay N
    Neuropediatrics; 2013 Aug; 44(4):208-12. PubMed ID: 23341096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maple syrup urine disease (MSUD): a case with long-term follow-up after liver transplantation.
    McLaughlin PM; Hinshaw J; Stringer AY
    Clin Neuropsychol; 2013; 27(7):1199-217. PubMed ID: 23829516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal case of classic maple syrup urine disease: usefulness of (1) H-MRS in early diagnosis.
    Sato T; Muroya K; Hanakawa J; Asakura Y; Aida N; Tomiyasu M; Tajima G; Hasegawa T; Adachi M
    Pediatr Int; 2014 Feb; 56(1):112-5. PubMed ID: 24548198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy.
    Felber SR; Sperl W; Chemelli A; Murr C; Wendel U
    Ann Neurol; 1993 Apr; 33(4):396-401. PubMed ID: 8489211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of brain stem auditory-evoked potential in maple syrup urine disease.
    Spankovich C; Lustig LR
    Otol Neurotol; 2007 Jun; 28(4):566-9. PubMed ID: 17414178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent maple syrup urine disease: two case reports.
    Axler O; Holmquist P
    Pediatrics; 2014 Feb; 133(2):e458-60. PubMed ID: 24394677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age dependence of diffusion-weighted magnetic resonance imaging findings in maple syrup urine disease encephalopathy.
    Sakai M; Inoue Y; Oba H; Ishiguro A; Sekiguchi K; Tsukune Y; Mitomo M; Nakamura H
    J Comput Assist Tomogr; 2005; 29(4):524-7. PubMed ID: 16012312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging findings of anaplastic astrocytoma in a child with maple syrup urine disease: a case report.
    Aw-Zoretic J; Wadhwani NR; Lulla RR; Ryan ME
    Childs Nerv Syst; 2015 Sep; 31(9):1625-9. PubMed ID: 26084772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral edema and intracranial hypertension in an adult with maple syrup urine disease.
    Sutter R; Killer HE; Bilz S; Baumgartner M; Ott HW; Steck AJ; Renaud S
    Eur J Neurol; 2009 Mar; 16(3):e45-6. PubMed ID: 19364339
    [No Abstract]   [Full Text] [Related]  

  • 18. [Maple syrup urine disease].
    Incesu L; Tasdemir HA; Yazicioglu AK; Belet U; Danaci M
    Radiol Med; 2001 Sep; 102(3):194-6. PubMed ID: 11677467
    [No Abstract]   [Full Text] [Related]  

  • 19. Maple syrup disease presenting as paroxysmal dystonia.
    Temudo T; Martins E; Poças F; Cruz R; Vilarinho L
    Ann Neurol; 2004 Nov; 56(5):749-50. PubMed ID: 15505779
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular characterization of maple syrup urine disease patients from Tunisia.
    Jaafar N; Moleirinho A; Kerkeni E; Monastiri K; Seboui H; Amorim A; Prata MJ; Quental S
    Gene; 2013 Mar; 517(1):116-9. PubMed ID: 23313820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.